Spice Maker Sizzles 5% Higher on Forecast Bump

A global irrigation firm is cashing in on Middle East demand, a retail pharmacy heavyweight is grinding through its turnaround with mixed results, and a spice giant is raising its outlook after a modest beat. Here’s what you need to know from this morning’s earnings action.

Gold recently smashed past $3,000—and one little-known U.S. company is sitting on over a million ounces of potential. 

Backed by a former Barrick Gold exec and fully permitted to begin development, this gold-copper explorer could be in the perfect position to benefit from rising prices. 

Even more bullish: the Trump administration is prioritizing critical minerals like gold and copper, streamlining permits and fast-tracking new projects.

Analysts have slapped an $18.75 target on this stock—and billionaire gold investor Eric Sprott is already on board.

This could be one of the most exciting gold stories in America right now.

Click here to see why this stock is gaining serious attention

Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone before the bell.

Email’s great. Texts are faster.

👉 Click here to get our pre-market report to your cell for free!

You’ll be first in line when the market starts moving.

Earnings:

Economic Reports:

Starting this July, big banks can legally treat gold as cash—and they’re wasting no time.

Meanwhile, millions of Americans are still heavily invested in volatile paper assets.

One economist says gold is now “the only money banks trust.”

There’s still time to catch up, using an IRS-approved method that avoids taxes or penalties.

This FREE Wealth Protection Guide explains how to move before the window closes.

[Click here to access the guide]

P.S. Every day you wait, the insiders move further ahead. Get the facts before July hits.

Spice and flavoring powerhouse McCormick & Company (MKC) delivered a solid second-quarter earnings report on Thursday, slightly beating expectations and providing a positive start to the consumer staples earnings season.

The company reported earnings per share of $0.69, ahead of the $0.66 consensus estimate, while revenue came in at $1.66 billion, exactly in line with forecasts and up 1% from the same period last year.

The report marks a turnaround from last quarter, when McCormick missed across key metrics and posted flat year-over-year sales. The company appears to be regaining momentum, aided by stable consumer demand and improved cost control.

Analysts had largely held their forecasts steady in the weeks leading up to the release, anticipating a steady-as-she-goes performance, and MKC delivered.

Importantly, McCormick raised its full-year earnings outlook to a range of $3.03–$3.08 per share, slightly ahead of the $3.02 Wall Street estimate. That guidance lift helped push the stock up roughly 5.6% in premarket trading.

While MKC shares have fallen 9.6% over the past three months, they’re still up 4.3% year over year and more with this premarket move. Investors will be watching closely to see if this quarter’s momentum carries into the second half of 2025, particularly as McCormick contends with ongoing inflationary pressures and fluctuating global demand.

With McCormick being the first major player in the consumer staples group to report, this modest beat and confident outlook could set a cautiously optimistic tone for the rest of the sector.

Lindsay Corporation (LNN), a major player in irrigation and infrastructure solutions, reported a strong fiscal third quarter, boosted by surging international demand and resilient infrastructure sales.

Total revenue increased 22% year over year to $169.5 million, driven by a 60% rise in international irrigation sales, primarily attributed to a large-scale project in the Middle East and North Africa (MENA) region.

Domestic irrigation revenue ticked up just 1% amid market concerns over tariffs and grain export disruptions, but overall irrigation segment sales jumped 25% to $143.7 million.

Infrastructure revenues also saw a healthy 6% bump, supported by seasonal road construction activity and increased demand for safety products.

Operating income rose 19% to $23.8 million, although net income slipped 4% to $19.5 million due to a one-time tax credit in the prior year that inflated last year’s bottom line. Diluted EPS for the quarter came in at $1.78, down from $1.85.

With improved margins in its irrigation segment and strong global execution, Lindsay's results reflect not only resilience in challenging markets but also growing traction in international project-based sales.

The company’s ability to offset tariff risks and capitalize on global infrastructure needs is positioning it well for continued momentum through year-end.

Shares are up in premarket trading — more than 2% higher.

As we dive into Q2 2025, the stock market is buzzing with opportunities, and I’ve got the insider scoop just for you.

I’ve handpicked the Top Seven Stocks for this quarter, offering you a clear roadmap for growth as the year progresses.

Here’s what makes this guide indispensable:

This isn’t merely a list; it’s your chance to seize the market’s hottest opportunities before they pass you by.

[Get Your Free Guide Now]

Walgreens Boots Alliance (WBA) reported a challenging fiscal third quarter, as rising costs and ongoing retail softness weighed on earnings despite stronger top-line results. Quarterly revenue rose 7.2% year over year to $39.0 billion, supported by pharmacy growth in the U.S. and improved performance in the international segment.

However, adjusted earnings per share fell to $0.38, down sharply from $0.63 a year ago and below investor expectations.

The headline net loss came in at $175 million, reversing a $344 million profit from the prior year. That swing was largely due to the absence of one-time investment gains recorded in 2024, as well as a higher tax bill this quarter.

On an adjusted basis, net income declined more than 39%, driven by weaker U.S. retail sales, higher incentive payouts, and softer equity contributions from Cencora.

Despite cost-saving progress and a rebound in the U.S. healthcare segment, Walgreens continues to face pressure in its core front-of-store business.

The retail division reported a 5.3% decline in sales, including a 2.4% decrease in comparable sales, with grocery, wellness, and beauty categories all underperforming. On the positive side, comparable pharmacy sales surged 14.6% and Boots UK retail comps rose 6.0% on a constant currency basis.

With its acquisition by Sycamore Partners still pending, Walgreens has withdrawn full-year guidance. CEO Tim Wentworth emphasized the company’s focus on executing its turnaround plan while prudently managing cash flow.

As legal settlements and inflation continue to weigh on performance, WBA’s next few quarters will be critical for rebuilding investor confidence.

IonQ is a leader in quantum computing, pioneering the use of trapped ion technology to build scalable quantum systems. Its mission is to tackle the kinds of complex calculations classical computers can’t handle, from pharmaceutical discovery to AI model training. The company’s approach has attracted high-profile partnerships with both commercial and government entities.

Shares are up more than 4% in premarket trading after the company released a new white paper highlighting breakthroughs in quantum gate fidelity and error correction, key steps toward practical, commercial-grade quantum computing. The move builds on strong YTD gains and surging institutional interest.

Altimmune is a clinical-stage biopharmaceutical company focused on developing treatments for liver disease and obesity. Its lead candidate, pemvidutide, has shown promising Phase 2 trial results for weight loss and liver fat reduction, potentially rivaling GLP-1 drugs like Ozempic and Wegovy.

The stock is rising 4% in premarket action today after a bullish analyst note from Jefferies, citing competitive efficacy with fewer side effects and the potential for oral delivery formats. It’s up over 30% this year and gaining attention as a sleeper GLP-1 contender.

MillerKnoll is a global design company known for its office furniture and home interiors, featuring the iconic Herman Miller and Knoll brands. As return-to-office trends and corporate renovations pick up, the company has started to bounce back from post-pandemic lows.

Shares jumped about 10% premarket after MLKN posted better-than-expected quarterly results, with revenue stabilizing and forward guidance raised. Cost-cutting and product innovation helped offset macro headwinds in commercial real estate and retail demand.

Gold is booming—and one U.S.-based company could be the ultimate way to play the rally without owning physical metal. 

It’s fully permitted, has a shovel-ready gold-copper project in Wyoming, and is backed by a former Barrick Gold executive. 

Plus, it just secured over $10M in financing and has earned a bullish $18.75 price target from analysts.

The company’s projects align perfectly with Trump’s push for “critical minerals” like gold and copper. 

With political tailwinds, top-tier assets, and a big-name investor on board, this could be a breakout waiting to happen.

Click here to get the full story on this American gold play

That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.

Best Regards,

— Adam Garcia
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.